These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12535821)

  • 1. In the statin era, how important are intense lifestyle changes?
    Parmley WW
    J Am Coll Cardiol; 2003 Jan; 41(2):273-4. PubMed ID: 12535821
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lifestyle-related diseases: Dyslipidemia].
    Moriyama T
    Nihon Jinzo Gakkai Shi; 2005; 47(1):8-16. PubMed ID: 15754758
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipids and prevention in coronary care.
    Betteridge DJ
    Trans Med Soc Lond; 1994-1995; 111():43-58. PubMed ID: 9156156
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of diabetic dyslipidemia.
    Garg A
    Am J Cardiol; 1998 Feb; 81(4A):47B-51B. PubMed ID: 9526814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-lowering drugs and homocysteine.
    de Lorgeril M; Salen P; Paillard F; Lacan P; Richard G
    Lancet; 1999 Jan; 353(9148):209-10. PubMed ID: 9923885
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease.
    Sdringola S; Nakagawa K; Nakagawa Y; Yusuf SW; Boccalandro F; Mullani N; Haynie M; Hess MJ; Gould KL
    J Am Coll Cardiol; 2003 Jan; 41(2):263-72. PubMed ID: 12535820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperlipidemia complicated with hypertension].
    Takagi S; Shimamoto K
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():738-42. PubMed ID: 11347164
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of education for lifestyle modification in patients with hyperlipidemia].
    Toyohara K; Kurisu A; Fukumoto T; Wada T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():518-23. PubMed ID: 11347124
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of dyslipidemia in adults with diabetes. American Diabetes Association.
    Diabetes Care; 1998 Jan; 21(1):179-82. PubMed ID: 9538989
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of hyperlipidaemia and therapy in renal patients.
    Wanner C
    Nephrol Dial Transplant; 2000; 15 Suppl 5():92-6. PubMed ID: 11073280
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of cholesterol lowering treatment on positive exercise tests in patients with hypercholesterolaemia and normal coronary angiograms.
    Mansur AP; Serrano CV; Nicolau JC; César LA; Ramires JA
    Heart; 1999 Dec; 82(6):689-93. PubMed ID: 10573494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management of hyperlipidemia/dyslipidemia.
    Kreisberg RA; Oberman A
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2445-61. PubMed ID: 12788840
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperlipidaemia and coronary risk. The Scottish Lipid Consensus Group.
    Scott Med J; 1991 Aug; 36(4):99-103. PubMed ID: 1815558
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention and therapy of atherosclerosis in childhood].
    Yu YH; Chen Y; Wang Y
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):547-50. PubMed ID: 16083569
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of hyperlipidaemia.
    Drug Ther Bull; 1996 Dec; 34(12):89-93. PubMed ID: 9018924
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of hyperlipidaemia. Why, when and how to treat.
    Oliver MF; Pyörälä K; Shepherd J
    Eur Heart J; 1997 Mar; 18(3):371-5. PubMed ID: 9076374
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid lowering: the case for identifying and treating the high-risk patient.
    Pearson TA; Swan HJ
    Cardiol Clin; 1996 Feb; 14(1):117-30. PubMed ID: 9072285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hyperlipidaemia.
    Thompson GR
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):337-42. PubMed ID: 8319362
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid-lowering therapy for coronary artery disease. Who and how to treat.
    Nash DT
    Postgrad Med; 1983 Nov; 74(5):308-9. PubMed ID: 6634528
    [No Abstract]   [Full Text] [Related]  

  • 20. Statin therapy in nephrotic syndrome.
    Chan NN
    J R Soc Med; 1999 Mar; 92(3):158. PubMed ID: 10396279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.